Clindamycin Hydrochloride Capsule
Product Images NDC 67296-1749

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 67296-1749). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

67296 1749 47

67296 1749 47
This is a description of two prescription drugs with the active ingredient Clindamycin HCL in capsules of 300mg each. The first drug package contains 30 capsules with Lot number CCG028X2 and the expiration date of 09/22, whereas the second drug package contains 28 capsules with Lot number CCG028X3 and the same expiration date. The usual adult dosage information is available in the package insert. The drugs should be stored within the controlled room temperature range of 20-25 C (68-77 F). The manufacturer is Micro Labs LTD located in Goa, India, and it is distributed by Redpharm Drug in Eden Prairie, MN. The NDC numbers for each drug package are 67296-1749-4 and 67296-1749-7, respectively.*
FDA Label Image

Label (67296 1749)

Label (67296 1749)
This is a description of Clindamycin HCL capsules containing 300mg of the medication. The NDC number, lot number, and expiration date are listed. The manufacturer, Micro Labs Limited, is located in Goa, India. It is stated to store the capsules at a controlled room temperature of 20-25 C (68-77 F). Usual adult dosage instructions can be found in the package insert. The capsules are distributed by Redpharm Drug in Eden Prairie, MN 55344.*
FDA Label Image

150 mg Label (Clindamycinhcl150mglabel)

150 mg Label (Clindamycinhcl150mglabel)
This is a description of a medication called "Clindamycin Hydrochloride Capsules, USP." Each capsule contains 150 mg of clindamycin hydrochloride. Dosage and use information is available in the accompanying prescribing information. The medication should be stored at a controlled room temperature of 20° to 25°C. The medication is made by Micro Labs Limited in India and is manufactured for Micro Labs USA Inc. The batch details can be found in the varnish-free area, and the product is only available with a prescription.*
FDA Label Image

300 mg Label (Clindamycinhcl300mglabel)

300 mg Label (Clindamycinhcl300mglabel)
This text is a product description for Clindamycin Hydrochloride Capsules, USP. Each capsule contains 300mg of clindamycin and the dosage and use instructions are available in the prescribing information. The product is stored at a controlled room temperature of 20-25°C (68-77°F) and is manufactured by Micro Labs Limited in Goa, India. It is distributed in the US by Micro Labs USA Inc. in Basking Ridge, NJ. Batch details can be found on the varnish-free area and the NDC number is 42571-252-01.*
FDA Label Image

75 mg Label (Clindamycinhcl75mglabel)

75 mg Label (Clindamycinhcl75mglabel)
This is a medication description for Clindamycin Hydrochloride Capsules. Each capsule contains 75mg of clindamycin hydrochloride. Dosage and usage details are not available in this text. The medication should be stored at a controlled room temperature of 20°C to 25°C. The NDC number is 42571-250-01 and the capsules are manufactured by Micro Labs Limited in Goa, India. The batch details are in the varnish-free area. The medication is manufactured for Micro Labs USA Inc. in Basking Ridge, NJ.*
FDA Label Image

Structure (Clindamycinhclstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.